AmDen Pharmaceuticals Denmark ApS — Credit Rating and Financial Key Figures

AmDen Pharmaceuticals Denmark ApS (CVR number: 42045403) is a company from STEVNS. The company recorded a gross profit of -7.5 kDKK in 2025. The operating profit was -7.5 kDKK, while net earnings were -4.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was -20.7 %, which can be considered poor and Return on Equity (ROE) was -24 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 58.5 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. AmDen Pharmaceuticals Denmark ApS's liquidity measured by quick ratio was 2.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.